Arkolith/Insider Trading/INVO/Form 4

Doody Kevin

Medical Director, DirectorINVO Bioscience, Inc. (INVO) · full profile →Form 4 · filed Jun 3, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$168K
Net Open-Market Flow
-$168K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2022Sell(P)177K$0.95$168K0

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-015904) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML